Tylenol Use in Babies, Children Raises Risk of Autism, New Review Shows

Julie Comber

The authors of a new review of the drug acetaminophen (paracetamol), sold under the brand names Tylenol and Panadol, are sounding the alarm about the use of the drug in infants and children, citing the drug’s association with autism spectrum disorder (ASD).

… The review, published in the July issue of Minerva Pediatrics, offers 17 lines of evidence that the commonly used remedy for pain and fever may be contributing to the autism pandemic.

… Their latest review builds on their earlier work showing acetaminophen was not assessed for impact on neurodevelopment, and on the strong evidence that prenatal exposure to acetaminophen increases the risks of neurodevelopmental issues.

You might also be interested in

Latest articles

Carolyn Beans How “forever chemicals” might impair the immune system Stain-resistant carpets...
Harold E. Buttram, Susan Kreider and Alan R. Yurko The writers of...
Carla Peeters A lingering disorder that can last for months or years...
el gato malo … the CDC just dramatically changed their claims about...

Your donation helps us
stand up for health freedom!

Canada Health Alliance is volunteer run and 100% supported by the generous donations of those who share our concerns and value our work.

Stay up to date

Sign up to our newsletter to get the latest health-related news and events delivered straight to your inbox.

Become a CHA member

Become an active value-added member and trusted provider of medical and healthcare information and education by joining the CHA Membership Program.

Your donation helps us stand up for healthcare choice!

Canada Health Alliance is volunteer run and 100% supported by the generous donations of those who share our concerns and value our work.

Thank you!

The form has been submitted successfully!